Examining the Feasibility of Clinical Grade CD271(+) Enrichment of Mesenchymal Stromal Cells for Bone Regeneration

INTRODUCTION: Current clinical trials utilize mesenchymal stromal cells (MSCs) expanded in culture, however these interventions carry considerable costs and concerns pertaining to culture-induced losses of potency. This study assessed the feasibility of new clinical-grade technology to obtain uncult...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuthbert, Richard J., Giannoudis, Peter V., Wang, Xiao N., Nicholson, Lindsay, Pawson, David, Lubenko, Anatole, Tan, Hiang B., Dickinson, Anne, McGonagle, Dennis, Jones, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356586/
https://www.ncbi.nlm.nih.gov/pubmed/25760857
http://dx.doi.org/10.1371/journal.pone.0117855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356586/
https://www.ncbi.nlm.nih.gov/pubmed/25760857
http://dx.doi.org/10.1371/journal.pone.0117855

Ejemplares similares